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Abstract
Background: Healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) infection in intensive care
unit (ICU) patients prolongs ICU stay and causes high mortality. Predicting HA-MRSA infection on admission can
strengthen precautions against MRSA transmission. This study aimed to clarify the risk factors for HA-MRSA
infection in an ICU from data obtained within 24 hours of patient ICU admission.
Methods: We prospectively studied HA-MRSA infection in 474 consecutive patients admitted for more than 2 days
to our medical, surgical, and trauma ICU in a tertiary referral hospital in Japan. Data obtained from patients within
24 hours of ICU admission on 11 prognostic variables possibly related to outcome were evaluated to predict
infection risk in the early phase of ICU stay. Stepwise multivariate logistic regression analysis was used to identify
independent risk factors for HA-MRSA infection.
Results: Thirty patients (6.3%) had MRSA infection, and 444 patients (93.7%) were infection-free. Intubation,
existence of open wound, treatment with antibiotics, and steroid administration, all occurring within 24 hours of
ICU admission, were detected as independent prognostic indicators. Patients with intubation or open wound
comprised 96.7% of MRSA-infected patients but only 57.4% of all patients admitted.
Conclusions: Four prognostic variables were found to be risk factors for HA-MRSA infection in ICU: intubation,
open wound, treatment with antibiotics, and steroid administration, all occurring within 24 hours of ICU admission.
Preemptive infection control in patients with these risk factors might effectively decrease HA-MRSA infection.
Background
Healthcare-associated methicillin-resistant Staphylococcus
aureus (HA-MRSA) infection in critically ill patients is
associated with prolonged intensive care unit (ICU) stay,
increased medical cost, and high mortality [1,2]. Further-
more, patients in the ICU have an increased susceptibility
to HA-MRSA infections [3,4]. Special risk factors make
such patients temporarily immunocompromised: normal
host defense mechanisms are often disrupted by multiple
invasive devices, impaired by underlying disease, and
reduced by medical interventions and medications. Over-
all, intrinsic together with extrinsic risk factors make the
ICU patient extremely vulnerable to HA-MRSA infections.
Therefore, control of HA-MRSA transmission and infec-
tion in the ICU is a serious concern.
Although most patients in the ICU are critically ill, to
perform infection control precautions for all ICU patients
would place an additional burden on medical staff and
might result in insufficient infection control. If the patients
at high risk of MRSA infection can be detected on ICU
admission, it may be possible to focus preemptive infec-
tion control measures on such patients and lessen the
workload of the ICU medical staff. The purpose of this
study was to clarify the risk factors of HA-MRSA infection
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Methods
Patient population
This was a prospective cohort study conducted from April
2009 to March 2010, during which time 1284 consecutive
patients were admitted to the ICU of Osaka General Med-
ical Center, Japan. Of these patients, 493 consecutive
patients who stayed in the ICU for more than 2 days were
included in the present study. Nineteen patients were
excluded from the analysis asb e i n gM R S A - p o s i t i v eo n
admission because MRSA was detected by the first screen-
ing culture within 2 days after ICU admission. Thus, a
total of 474 patients comprised the study group.
This study followed the principles of the Declaration of
Helsinki. The conduction of this study was approved by
the institutional review board at Osaka General Medical
Center. The board waived the need for informed consent
because we have taken the samples for surveillance not
purely for the purpose of this study.
Infection control policy
The Osaka General Medical Center is a 768-bed, acute,
tertiary referral hospital. The 18-bed ICU is both a medical
and surgical ICU with large numbers of trauma patients.
Standard precautions, such as hand hygiene with alcohol
gel or soap before and after patient care, are used for all
patients, regardless of multidrug-resistant organisms
(MDRO) colonization status. In addition, MDRO-colo-
nized patients are placed in isolation, and contact precau-
tions, such as the wearing of disposable gowns, gloves, and
masks during the care of these patients, are performed.
Contact precautions were also applied to the patients
transferred from other hospitals until MRSA status could
be proven to be negative by surveillance culture.
Data collection
We performed surveillance culture of sputum, nasal
excretions, and urine when patients were enrolled. Nasal,
pharyngeal, and wound specimens were obtained with
cotton-tipped sticks. Surveillance cultures were contin-
ued once every week while the patients remained in the
ICU. Other clinical cultures were performed when
needed.
Clinical samples were processed according to routine
microbiology procedures. Gram-positive cocci were tested
for catalase production, and catalase-positive colonies
were then tested for coagulase. Any coagulase-positive col-
ony was subcultured onto non-selective blood agar for
identification and susceptibility testing. Antibiotic suscept-
ibility pattern was determined using the Vitek 1 system
(Sysmex bioMérieux Co., Ltd., Tokyo, Japan), following
the criteria of the Clinical and Laboratory Standards Insti-
tute. Genotypic analysis of the strains was not performed.
The patients whose surveillance or clinical cultures
became positive for MRSA after enrollment were defined
as “HA-MRSA acquisition.” Acquisition included apparent
infection and/or colonization by MRSA. Infection was
diagnosed according to the Centers for Disease Control
and Prevention National Nosocomial Infections Surveil-
lance System definitions [5]. We evaluated the rate of
healthcare acquisition and/or apparent infection with
MRSA. Follow-up was for the duration of the ICU stay.
We assessed a total of 11 candidate prognostic variables
possibly related to MRSA infection: baseline characteristics
(age and sex), severe sepsis, severe trauma, existence of
open wound, history of emergency operation, intubation,
insertion of central venous catheters (CVCs), antibiotics
administration, steroid administration, and transfer from
another hospital. Detailed definitions of each variable are
shown in Table 1. Data on all variables used in this study
were obtained within 24 hours of ICU admission to pre-
dict the risk of infection in the early phase of ICU stay.
Statistical analysis
The most important prognostic variables were selected
as follows. First, univariate logistic regression analysis
was conducted to find potential prognostic variables;
variables with a P-value > 0.20 were excluded. Second,
stepwise multivariate logistic regression analysis was
performed to identify independent risk factors for HA-
MRSA infection. Finally, we examined sensitivity and
specificity for HA-MRSA infection of each combination
of risk factors. A P-value of < 0.05 was considered to be
statistically significant. Statistical analyses were per-
formed with SPSS version 17.0 for Windows (SPSS Inc.,
Chicago, IL).
Results
The overall incidence of HA-MRSA infection is shown in
Figure 1. In a total of 474 patients negative for MRSA on
ICU admission, 30 patients (6.3%) were infected with
MRSA and 444 patients (93.7%) had no infection. HA-
MRSA infections were classified as pneumoniae (n = 12),
burn wound infection (n = 7), soft tissue infection (n =
4), surgical site infection (n = 3), bone and joint infection
(n = 2), gastroenteritis (n = 1), and bloodstream infection
(n = 1).
The results of univariate analysis are shown in Table 2.
Seven variables were significantly associated with HA-
MRSA infection: severe sepsis (n = 44), open wound (n =
42), emergency operation (n = 84), intubation (n = 252),
CVCs (n = 114), treatment with antibiotics (n = 244),
and steroid administration (n = 43). Because there was
no apparent relation between HA-MRSA infection and
the variables severe trauma (n = 91) and transfer from
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excluded as candidates for further analysis by multivari-
ate logistic regression. Consequently, four risk factors
were selected by multivariate logistic regression: intuba-
tion, open wound, treatment with antibiotics, and steroid
administration (Table 3).
The sensitivity for occurrence of MRSA infection was
plotted based on the number of patients with at least
one of these four independent risk factors as shown in
Figure 2. Infection control precautions are considered to
be reasonable when targeting the small group of patients
with the highest sensitivity for acquisition of MRSA
infection, which is indicated by the ellipse in Figure 2.
The factors within the ellipse are shown in Table 4. All
five of these various combinations of risk factors for
MRSA infection showed high sensitivity (96.7% - 100%).
Additionally, the number of patients to target comprised
between 53.8% and 61.6% of all patients admitted to the
ICU during the study period. As a result, if we perform
preemptive infection control measures on intubated
Table 1 Definitions of 11 candidate prognostic variables possibly related to MRSA infection
Variable Definition
Age Years
Sex Male or female
Severe sepsis According to the criteria of the ACCP/SCCM consensus conference committee
Severe trauma AIS score greater than 2 for at least one region
Open wound Existence of open wound within 24 hrs of ICU admission
Emergency operation Emergency operation within 24 hrs of ICU admission
Intubation Intubation within 24 hrs, except extubation within 24 hrs of ICU admission
CVCs Insertion of central venous catheters within 24 hrs of ICU admission
Antibiotics Antibiotics administration within 24 hrs of ICU admission
Steroid History of steroid use or steroid administration within 24 hrs of ICU admission
Transferred Transferred from another hospital
MRSA: methicillin-resistant Staphylococcus aureus; ACCP/SCCM: American College of Chest Physicians/Society of Critical Care Medicine; AIS: abbreviated injury
scale; CVCs: central venous catheters.
Figure 1 Flowchart showing overall incidence of acquisition and infection with healthcare-associated MRSA in the present study.
MRSA: methicillin-resistant Staphylococcus aureus; ICU: intensive care unit.
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96.7% of the patients infected with HA-MRSA, and the
number of patients with these two factors would be lim-
ited to just 57.4% of all patients admitted.
Discussion
We evaluated risk factors for infection with HA-MRSA
during the ICU stay by multivariate logistic regression
analysis. Because we plan to introduce preemptive infec-
tion control measures for patients at high risk of HA-
MRSA infection in the near future, only the factors
obtained within 24 hours of ICU admission were sampled
as possible prognostic variables in this study. To our
knowledge, there are no previously published data on risk
factors for MRSA infection analyzed from such a point of
view. Our results showed that four risk factors were inde-
pendently associated with HA-MRSA infection: intubation,
open wound, treatment with antibiotics, and steroid
administration, all occurring within 24 hours of admission
to the ICU.
Several reports concerning the risk factors of HA-MRSA
infection have been published. Ibelings and coworkers
reported that patients in the ICU are at high risk of MRSA
infection, and patients with MRSA infections are less likely
to survive than those with methicillin-sensitive Staphylo-
coccus aureus [3]. In addition, several factors related to
MRSA transmission and infection were reported, such as
length of ICU stay [2], antibiotics administration [6,7], pre-
vious hospital stay [8], history of surgery [8], trauma
patients [9], burn patients [10], presence of CVCs [11],
and steroid administration [12]. Referring to these reports,
we extracted 11 candidate prognostic variables that were
possibly related to MRSA infection and that could be
assessed within 24 hours of ICU admission. Although the
length of ICU stay is strongly related to MRSA infection,
this factor cannot be determined within the first 24 hours
o fI C Ua d m i s s i o n .A c c o r d i n g l y ,w ee x c l u d e dt h i sf a c t o r
from the prognostic variables in this study. We also con-
sidered using a severity score, such as the Acute Physiol-
ogy and Chronic Health Evaluation score or the Simplified
Acute Physiology Score II score, as a prognostic variable.
However, the complicated prediction calculation formulas
of these scoring systems were not suitable in clinical prac-
tice, so severity scores were not considered in this study.
Although the risk factors detected in this study other
than intubation did not contradict those of previous stu-
dies [6,7,10,12], no previously published data, to our
knowledge, has focused on intubation as a risk factor for
HA-MRSA infection. There were several reasons why
intubation was selected as one of the independent risk fac-
tors. First, the frequency of medical staff contact is high
for the intubated patient compared with that for other
patients. In an intubated patient, frequent nursing care
such as suctioning of secretions, oral care, and postural
change are necessary. As a result, the opportunity for
MRSA transmission will increase. Second, patients who
require ventilatory support may be severely ill. It has been
shown that severely ill patients tend to acquire MRSA
infection [3].
The costs of MRSA infection in terms of added morbid-
ity, mortality, hospital days, and hospital charges are over-
whelming [1,2]. Although ‘time-dependent bias’ reportedly
gives estimates that greatly overestimate the effect of noso-
comial infection on the extra length of ICU stay [13], sev-
eral studies have indicated that MRSA infections cause a
significant additional length of stay or financial burden
after adjustment for the factors that truly influence the
length of stay [2,14,15]. The spread of MRSA occurs
mainly from person to person [16]. Therefore, control of
MRSA transmission and infection is of serious concern.
The findings of this study should be helpful in formulating
and implementing several strategies for reducing the risk
of MRSA infection. If we strengthen preemptive infection
control in high-risk patients, we may be able to decrease
the rate of healthcare-associated infection. We found that
patients with 2 or 3 risk factors included nearly 100% of
MRSA-infected patients, whereas those factors were lim-
ited to about one half of all patients admitted, as shown in
Table 4. We believe that the two factors of intubation and
open wound are the best combination to address. The
Table 3 Results of multivariate logistic regression
analysis
Covariate Coeff(b) SE(b) OR 95% CI P-value
Intubation (1 or 0) 1.961 0.651 7.109 1.983 - 25.485 0.002
Open wound (1 or 0) 1.944 0.483 6.985 2.710 - 18.005 < 0.001
Antibiotics (1 or 0) 1.625 0.646 5.078 1.433 - 17.999 0.012
Steroid (1 or 0) 1.537 0.551 4.652 1.579 - 13.709 0.005
Coeff(b): coefficient; SE(b): standard error of coefficient; OR: odds ratio; 95% CI:
95% confidential interval.
Table 2 Results of univariate analysis of variables related
to MRSA infection
Variable P-value
Age 0.053
Sex 0.151
Severe sepsis < 0.001
Severe trauma 0.552
Open wound < 0.001
Emergency operation 0.021
Intubation < 0.001
CVCs < 0.001
Antibiotics < 0.001
Steroid 0.005
Transferred 0.485
MRSA: methicillin-resistant
Staphylococcus aureus; CVCs: central venous catheters.
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obvious to detect, so that it is easy for the medical staff to
judge whether the patient is positive for these factors.
Conversely, it is hard to identify visually whether the
patient is being treated with antibiotics or steroids at ICU
admission. In addition, there are a large variety of uses for
antibiotics and steroids. Because prophylactic use of anti-
biotics [17-19] and MPSS therapy for spinal cord injury
[20] are still controversial therapies, these indications may
change in the future. Furthermore, even if treatment with
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Figure 2 Sensitivity for MRSA infection and number of patients with risk factors. Sensitivity for MRSA infection is plotted according to the
number of patients with at least one of the four independent risk factors identified in the present study. A closed circle indicates sensitivity and
number of patients with at least one of the 4 factors, an open circle indicates sensitivity and number of patients with at least one of 3 factors,
an open square indicates sensitivity and number of patients with at least one of 2 factors, and a closed triangle indicates sensitivity and number
of patients with only 1 factor. The combinations circumscribed by the ellipse were the best subset of a small group of patients with the highest
sensitivity for MRSA infection. MRSA: methicillin-resistant Staphylococcus aureus; INT: intubation; OW: open wound; TA: treatment with antibiotics;
ST: steroid administration.
Table 4 Sensitivity and specificity for MRSA infection
Sensitivity (%) Specificity (%) Number of patients (%)
Intubation or open wound 29/30 (96.7) 201/444 (45.3) 272/474 (57.4)
Intubation or steroid 29/30 (96.7) 200/444 (45.1) 273/474 (57.6)
Open wound or antibiotics 29/30 (96.7) 218/444 (49.1) 255/474 (53.8)
Intubation or open wound or steroid 30/30 (100) 182/444 (41.0) 292/474 (61.4)
Open wound or antibiotics or steroid 30/30 (100) 196/444 (44.1) 278/474 (58.6)
MRSA: methicillin-resistant Staphylococcus aureus.
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along with the two factors of intubation and open wound,
the sensitivity for acquisition of MRSA infection would be
almost the same as that for the two factors alone.
We excluded the patients with preexisting MRSA on
ICU admission because the purpose of this study was to
identify the risk factors for healthcare-associated (nosoco-
mial) MRSA infection in the patients who did not harbor
MRSA at the time of ICU admission. Our goal was to
identify the patients vulnerable to MRSA infection. We
think this is very important from the viewpoint of nosoco-
mial infection control. Patients with preexisting MRSA on
ICU admission are an important group because they are a
source of MRSA and of development of infection. We also
separately investigated predictors of infection for patients
with preexisting MRSA (data not shown). The number of
patients in this study with MRSA on ICU admission was
19 patients, and of them, 9 patients (47%) developed infec-
tion during their ICU stay. Due to this small number of
patients, we analyzed the risk factor of MRSA infection by
univariate analysis alone, and only ‘transferred from
another hospital’ was detected as a significant risk factor.
We have already introduced contact precautions for trans-
ferred patients until their MRSA status can be proven to
be negative by surveillance culture.
We acknowledge several limitations in this study. First,
the sample size was small because the study duration was
only 1 year. Second, this study was carried out in a single
institution. Because there is epidemiologic variation in
healthcare-associated infection among institutions, results
potentially may not be universally applicable. Third, exter-
nal validation was not performed in this study. It was diffi-
cult to divide the patients to developing and validating
data set due to the small sample size of patients with
MRSA infection (n = 30) in this study. In the future, it will
be necessary to perform an external validation analysis or
to examine whether preemptive infection control for
patients with high-risk factors actually works effectively.
Fourth, patients intubated after the first 24 hours from
ICU admission were not investigated. Because those
patients will also be at high risk for MRSA infection in
terms of disease severity and contact incidence with medi-
cal workers, they should also be targeted for preemptive
infection control. Our preliminary study warrants further
multicenter investigation, and we are presently in the pro-
cess of conducting a prospective multi-institutional cohort
study to assess the effect of focused preemptive infection
control according to risk factors for HA-MRSA infection
revealed in the present study.
Conclusions
In the present study, we analyzed risk factors for HA-
MRSA infection in an ICU from data obtained within
24 hours of patient ICU admission. Consequently, four
prognostic variables were selected: intubation, open
wound, treatment with antibiotics, and steroid adminis-
tration, all occurring within 24 hours of ICU admission.
Patients with the two factors of intubation or open
wound included nearly 100% of the patients infected
with MRSA, whereas patients with these factors were
limited to about one half of all admissions to the ICU.
Further investigation of the effectiveness of preemptive
infection control to reduce HA-MRSA infection in these
selected patients in the ICU setting is required.
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